Characterisation of two new HLA-A alleles: HLA-A*01:454 and HLA-A*31:229.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
May 2024
Historique:
revised: 27 04 2024
received: 25 04 2024
accepted: 30 04 2024
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 9 5 2024
Statut: ppublish

Résumé

HLA-A*01:454 and HLA-A*31:229, two novel HLA-A alleles detected during routine typing by next-generation sequencing.

Identifiants

pubmed: 38721702
doi: 10.1111/tan.15519
doi:

Substances chimiques

HLA-A Antigens 0
HLA-A1 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15519

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. IPD‐IMGT/HLA Database. Nucleic Acids Res. 2023;51:D1053‐D1060.
Simakova T, Suvorova A, Krivonosova K, Abramova A, Loginova M, Paramonov I. NovAT tool—reliable novel HLA alleles identification from next generation sequencing data. HLA. 2022;99(1):3‐11.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291‐455.

Auteurs

Maria Loginova (M)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.
Federal State Budget Educational Institution of Higher Professional Education: Vyatka State University, Kirov, Russia.

Daria Smirnova (D)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Igor Paramonov (I)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH